Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...

Medically reviewed by Archana Sharma, DO Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside ...

Key Takeaways SENTI-202 targets CD33 or FLT3, sparing EMCN, enhancing precision in treating hematologic malignancies like AML. Preliminary data shows high efficacy, with significant composite complete ...

Study unveils key immune cells found to boost cancer treatment success in acute myeloid leukemia New computational tool aims to identify immune responses to cellular therapy in AML treatments Date ...

In this video, Moath Albliwi, MD, discusses the results of a study he co-presented at ASH Annual Meeting and Exposition that examined treatment of elderly patients with acute myeloid leukemia ...

More information: Stefanie Weiss et al, Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia, Cancer Letters (2025). DOI: 10.1016/j.canlet.2025.217501 ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid ...

CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant. Nature Cancer, 2025; DOI: 10.1038/s43018-025-00934-1 ...

MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment.Sophie Paczesny, M.D., Ph.D., the principal investi ...